Who to call at Rani Therapeutics Holdings, Inc., and when
Fundz watches for the moments Rani Therapeutics Holdings, Inc. starts buying, and tells you who to reach.
- An alert the day Rani Therapeutics Holdings, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rani Therapeutics Holdings, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rani Therapeutics Holdings, Inc.. With Fundz connected, it knows.
Rani Therapeutics Holdings, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
AI Executive Summary
AI-powered analysis of 8-K filing content
Rani Therapeutics directors Andrew Farquharson and Maulik Nanavaty resigned from the board and all committees, effective upon closing of a Private Placement, as disclosed on October 22, 2025. The excerpt does not state the placement's terms or the reasons for the resignations, but the timing ties the board changes to a financing.
Key Takeaways
Two directors, Andrew Farquharson and Maulik Nanavaty, notified Rani Therapeutics of their resignations from the board and all committees on October 22, 2025.
The resignations take effect only upon the closing of a Private Placement, which links the board changes to a pending financing transaction.
2 more takeaways
Related Filings (7)
7 more filings from Rani Therapeutics Holdings, Inc. in the last 90 days
Filing Overview
What This Means
Rani Therapeutics Holdings, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.